Skip to main content
. 2021 Jan 19;28(2):183–191. doi: 10.1002/jhbp.877

TABLE 4.

Demographics and clinical characteristics of main pancreatic duct injured patients initially treated with operative and nonoperative management

Variables

Nonoperative management

n = 11

Operative management

n = 53

P value
Background
Age (y) 49.5 ± 6.9 35.9 ± 3.1 .079
Injury type
Blunt 11 (100) 51 (96) .513
Penetrating 0 (0) 2 (4)
Intraabdominal injury
Pancreas only 5 (45) 27 (51) .740
Pancreas injury location
Head 4 (36) 15 (28) .594
Body or tail 7 (64) 38 (72)
Rate of comorbidities 5 (45) 10 (23) .058
Injury Severity Score (ISS) 14.7 ± 2.5 15.4 ± 1.1 .814
Laboratory values
WBC (/μL) 12,825 ± 1634 13,577 ± 744 .677
CRP (mg/dL) 2.9 ± 2.2 3.2 ± 1.0 .895
Amylase (U/L) 562.8 ± 205.7 482.6 ± 91.1 .723
Treatment
Rate of ERP 6 (55) 22 (42) .428
Outcomes
Complications a 9 (82) 29 (55) .096
Pseudocyst b 4 (36) 6 (11)
Pancreatic fistula b 4 (36) 22 (42)
Abscess b 2 (18) 10 (19)
Peritonitis b 2 (18) 2 (4)
Conversion to surgery 5 (45)
Hospital stay (d) 77.3 ± 13.0 47.2 ± 5.7 .038
Mortality 0 (0) 2 (4) .513

Frequency (%) for categorical variables.

Mean (standard deviation [SD]) for continuous variables.

Abbreviations: CRP, C‐reactive protein; ERP, endoscopic retrograde pancreatography; WBC, white blood cell.

a

Clavien–Dindo classification of grade IIIa or higher.

b

Overlapping distribution.